A 47-year-old lady (index case) with diabetes and deafness showed multiple oval circumferential areas of perifoveal atrophy in both eyes. Autofluorescence revealed areas of hypoautofluorescence. Optical coherence tomography (OCT) showed depression of inner retinal surface, inner retinal hyporeflective spaces (pseudocysts), disorganization/thinning of outer retina, outer retinal tubulation, loss of external limiting membrane, ellipsoid and interdigitation zone, and thinning of the retinal pigment epithelium and choriocapillaris. The patient was evaluated using OCT angiogram. Retinal lesions of her mother (68-year-old) were very obvious on autofluorescence imaging. The result of A3243G mutation in MTTL1 gene was positive in the index case confirming the diagnosis of maternally inherited diabetes and deafness (MIDD).
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Case Reports
Case 1 A 47-year-old lady with short stature (145 cm) had type 2 diabetes mellitus for the last 20 years. She had a history of severe sensorineural hearing loss for 12 years and ischemic heart disease for 5 years. Her mother and maternal aunt had developed diabetes and deafness before the age of 40 years. Her siblings and son had no systemic complaints. The best-corrected visual acuity (BCVA) was 20/20p in both eyes (right eye -4.75 DS, left eye -5.00 DS). Anterior segment and intraocular pressure were unremarkable in both eyes. The fundus showed well-defined, round to oval areas of atrophy surrounding the fovea in a circumferential manner in both eyes [ Fig. 1a and b] which is very similar to the ocular features of MIDD. Autofluorescence accentuated the appearance and showed sharply defined discontinuous areas of perifoveal hypoautofluorescence surrounded by speckled hyper autofluorescence which was not clinically obvious 
Case 2
Mother of the index case was a 68-year-old female. She had posterior subcapsular cataract in both eyes (right > left). BCVA was 20/30 in the right eye and 20/20p in the left eye. She had barely visible RPE changes around the fovea and the optic disc [ Fig. 4a and b] which became obvious with autofluorescence imaging [ Fig. 4c and d]. Case 1 was noted to have A3243G mutation in MTTL1 gene using Sanger sequencing. Due to financial constraints, the genetic analysis of family members could not be performed.
Discussion
The occurrence of characteristic macular changes in this family with diabetes and deafness was a clue for MIDD [3] which was further confirmed by the presence of MTTL1 gene mutation in the index case. MIDD can be caused by mutation of multiple mitochondrial genes including MTTL1 (commonest), MTTE, and MTTK. A3243G mutation can also cause MELAS (mitochondrial encephalopathy, lactic acidosis, stroke-like episodes). The absence of systemic complaints in the siblings and son of the index case may be related to clinical variability due to heteroplasmy. However, they were advised a systemic evaluation for any occult disease.
Our patient had multiple areas of perifoveal atrophy on clinical exam, which was much more prominent with autofluorescence. The autofluorescence also showed speckled fluorescence around the clinically obvious lesions, which has been considered an important feature of MIDD. [2] Speckled autofluorescence which is more severe than clinical appearance is also noted in maculopathy due to dominant R172W (RDS) mutation. [2] However, unlike MIDD, the fovea is involved in R172W mutation and the autofluorescence changes are usually confined within the arcades and around the optic nerve. [2] OCT showed inner retinal pseudocysts (hyporeflective spaces) in our case which is seen in 27% of eyes with geographic atrophy. [4] These small cystoid spaces were noted at the inner nuclear layer (41.6%), deep outer retinal layers (29.1%), in all retinal layers (12.5%), at the outer nuclear layer (12.5%), and just below the internal limiting membrane (4.1%) by Cohen and colleagues. [4] These were not associated with choroidal neovascular membrane (CNVM) and were hypothesized to be due to Muller cell degeneration [4] in atrophic age-related macular degeneration (AMD).
ORT has been reported in MIDD. [5, 6] Zweifel SA and colleagues [6] were the first to describe ORT in neovascular AMD, CNVM in pseudoxanthoma elasticum and multifocal choroiditis and panuveitis, central serous chorioretinopathy, geographic atrophy, Bietti crystalline dystrophy, choroideremia, tissue inhibitor of metalloproteinase-3 negative pattern dystrophy, and 'retinal degeneration phenotypically consistent with a mitochondrial A3243G mutation'. ORTs appear as tubules which may be branching, straight, or composed of 'complex cavitary networks' on C scan OCT. On B scan OCT, ORTs appear as round or oval hyporeflective spaces surrounded by hyperreflective margins in the outer retina usually over areas of subretinal fibrosis or areas of retinal pigment epithelial abnormality. [6] ORT is a feature of degeneration of photoreceptors and does not require therapy. Pseudocyst and ORT in MIDD suggest that along with Muller cell degeneration there is photoreceptor degradation in the affected areas. ORT is limited only to the atrophic area.
OCT angiogram (OCTA) showed choriocapillaris voids before the development of the atrophy in MIDD. [7] Zhioua Braham and colleagues have described that OCTA 'showed foveal avascular zone enlargement, areas of retinal capillary rarefaction in superficial and deep capillary plexuses'. [8] In our patient, the choriocapillaris void areas were noted in the uninvolved foveal region as well as the atrophic regions to varying degrees, which may be indicative of progression of the disease. Features of progressive atrophy were noted in areas surrounding the patches on fundus photo image in the FAF image which was confirmed by OCTA.
Conclusion
In conclusion, the classic appearance helped us to the final diagnosis of MIDD and we describe the OCTA features of the disease. 
Commentary: Heteroplasmy in maternally inherited diabetes and deafness
Maternally inherited diabetes and deafness (MIDD) is a mitochondrially inherited disease. Mitochondrial DNA is inherited from the mother and its defects affect organs that demand higher energy such as the eye, inner ear, central nervous system, skeletal, and cardiac muscle. MIDD is associated with early onset diabetes and sensorineural deafness. The various other systemic features reported include cardiomyopathy, renal problems, and neuropsychiatric symptoms. Pigmentary retinal dystrophy is the most common ophthalmic manifestation. [1] The prevalence of MIDD ranges from 0.5% to 2.8%. [2] MIDD has been reported to be associated with mutations, such as MT-TL1 and MT-TK of which MT-TL1 is the most common. [3] Tripathy K et al. have noted A3243G mutation in MT-TL1 gene using Sanger sequencing in one of their subject. [4] The A3243G mitochondrial mutation is seen with a wide range of mitochondrial encephalomyopathies including MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke) or MELAS/MERRF (myoclonic epilepsy, red ragged fibers) overlap syndrome. [5] However, the same mutation can cause different phenotypes. The phenotypic variability is determined by the degree of heteroplasmy. [6] The authors too noted a difference in the phenotypes within the family members and related it to heteroplasmy.
Heteroplasmy is the presence of more than one type of organellar genome (mitochondrial DNA or plastid DNA) within a cell or individual. It is an important factor in considering the severity of mitochondrial diseases. The most frequent findings in A3243G mutation-positive participants was hearing loss and macular disturbance, with 95% of mutation-positive relatives having hearing loss. [5] Macular disturbance is in the form of a pattern dystrophy -an important clinical sign in the diagnosis of MIDD. There are three grades for this manifestation: Grade 1: Severe punctate pigment dots in the macula; Grade 2: A butterfly or reticular pattern; and Grade 3: Multifocal or a continuous perifoveal atrophy of the RPE. [5] [6] [7] [8] The variability of the manifestations could be attributed to the heteroplasmy in MIDD.
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